Company intelligence / Profile preview
Applied Biological Laboratories
- Ownership
- Private
- Employees
- ~9
- Development stage
- Commercial
Overview
Biovanta, the company’s flagship product line, consists of patented and clinically tested over-the-counter drugs targeting common respiratory viruses and related symptoms. The company claims superior efficacy compared to leading brands in both safety and effectiveness. Clinical studies focus on cytokine modulation and prevention of bradykinin-induced inflammation relevant to sore throat and COVID‑19 complications. However, the FDA has issued warnings regarding unapproved marketing claims related to COVID‑19 treatment/prevention.
- Therapeutic areas
- PulmonologyInfectious Diseases
- Modalities
- Natural small molecules (including aspirin-based formulations)
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Applied Biological Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Applied Biological Laboratories.